Founder · Executive · Operator
Karen Chu
Karen Chu is the founder and CEO of HiRO (Harvest Integrated Research Organization), a boutique global contract research organization that bridges clinical trials between Asia, the US, and Europe. A PharmD who spent nearly two decades at Parexel running global clinical operations across 50-plus countries, she launched HiRO in 2020 to help Asian biotechs run trials abroad and Western firms run trials in Asia. Under her leadership the company has expanded through acquisitions including Courante Oncology in the US and PharmaSols in Australia and New Zealand, while positioning itself as global in reach but deliberately mid-sized in ambition.